When I was reading the slides from the conference I came across the above. I don't really know much about this. On the European Medicines Agency I found out that the orphan designation was granted in 2007 for the development of Factor H and it is thought that the supplementation of purified factor H would alleviate the disease. It also says that the evaluation of the effects of complement factor H in experimental models is ongoing.
It was in 2007...would anybody know whether there's been any progress with this? Could this actually mean that it would have the potential to restore a normal capacity to regulate complement activity. I would be grateful for any information.